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Abstract On-going research aims at answering the question,
which satiety signal is the most potent or which combination
of satiety signals is the most potent to stop eating. There is also
an aim at finding certain food items or food additives that
could be used to specifically reduce food intake therapeutical-
ly. Therapeutic attempts to normalize body weight and
glycaemia with single agents alone have generally been dis-
appointing. The success of bariatric surgery illustrates the ra-
tionale of using several hormones to treat obesity and type-2-
diabetes. We have found that certain components from green
leaves, the thylakoids, when given orally have a similar ratio-
nale in inducing the release of several gut hormones at the
same time. In this way satiety is promoted and hunger sup-
pressed, leading to loss of body weight and body fat. The
mechanism is a reduced rate of intestinal lipid hydrolysis,
allowing the lipolytic products to reach the distal intestine
and release satiety hormones. The thylakoids also regulate
glucose uptake in the intestine and influences microbiota com-
position in the intestine in a prebiotic direction. Using thyla-
koids is a novel strategy for treatment and prevention of
obesity.
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Abbreviations
CCK Cholecystokinin
DEXA Dual-energy X-ray absorptiometry
GLP-1 Glukagon-like peptide-1
PPARs Peroxisome proliferator-activated receptors
TNF-alfa Tumour necrotic factor-alfa
VAS Visual analogous scale
Introduction
Obesity epidemic spreads rapidly over the world. The origin
of obesity epidemic is clearly dependent on several parame-
ters. One such is the increased consumption of energy-dense
and nutrient-poor food, containing high levels of fat and su-
crose [1].
Appetite control occurs through two systems, the homeo-
static regulation and the hedonic regulation [2]. The homeo-
static regulation involves control of energy intake and the
hedonic regulation the control of sensory pleasure in eating.
The loss of effective appetite control could either be due to a
disturbance in the homeostatic pathway and/or an inappropri-
ate sensitization of the hedonic pathway.
There is clearly an interaction between the homeostatic and
hedonic systems [3]. Together they will modulate hunger and
satiety but also the choice and liking of certain food items. To
achieve appetite control and to be able to influence body
weight regulation it is hence important to consider the pro-
cesses responsible for energy homeostasis and the processes
involved in the hedonics of eating [4]. One important factor
contributing to appetite control is the bacterial flora in the
intestine.
We have found that thylakoids, the photosynthetic mem-
branes of green leaves, suppress hunger and promote satiety.
This occurs through the modulation of gastrointestinal
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appetite peptides and a modulation of the gut microflora. In
long-term studies the thylakoids produce weight loss together
with a reduction of blood lipids and blood glucose. Subjects
receiving thylakoids also have a decreased liking for fat and
sweet. Thylakoids when added to food may therefore be help-
ful in achieving weight loss and improved health.
Thylakoids - Properties and Composition
Thylakoids are the membranes in the chloroplasts of green
leaves responsible for the light reaction in photosynthesis
(Fig. 1) [5, 6]. They are probably the most complex of
biological membranes and organized into continuous
paired membranes having different composition and func-
tion. The thylakoids contain over 100 different proteins,
both intrinsic and extrinsic, together with membrane lipids
and pigments. The thylakoids are located in chloroplasts
of green leaves and at a higher concentration in dark
green leaves compared to light green leaves. Characteris-
tic of the proteins is that they are membrane spanning,
which means that they are hydrophobic and attract to hy-
drophobic surfaces like lipids. The thylakoids have an iso-
electric pH at 4,7 [7]. This means that they are positively
charged at a pH below 4,7 and negatively charged above
pH 4,7. In the stomach the pH is close to 2,0 during
fasting conditions. During a meal the pH of gastric con-
tents increases up to 6–7 depending on the food compo-
nents and remains much above pH 2 until most of the
meal is emptied. In the intestine pH is like-wise around
6,5 in the lumen. This means that the thylakoids are neg-
atively charged and can bind positively charged ions. In
the lumen of the intestine thylakoids form large swollen
structures that adhere to the mucosal surface [8]. The mu-
cosal surface of the intestine pH has an acidic pH, around
5,3 [9]. The thylakoids thus are rather isoelectric at the
mucosal surface and hence easily adsorb to this, as has
been demonstrated [8].
The thylakoids besides proteins contain phospholipids, ga-
lactolipids and pigments building up the membrane. The thy-
lakoids are built as stacks, which connect to each other
through a grana structure (Fig. 1). Together they form a tightly
compressed and stable three-dimensional structure that is able
to withstand outer forces from the environment but still retain
a great flexibility. In the stomach and the intestine thylakoids
are resistant to degradation by gastric and pancreatic enzymes
[10]. This is an important property, since the thylakoids there-
by remain in the intestine for several hours, before they get
totally degraded. Through this stability food digestion in the
presence of thylakoids goes on for a long time allowing the
digestive products to reach the distal intestine to release satiety
hormones. Pancreatic lipase-related protein 2, a lipase not be-
ing dependent on colipase, hydrolyses galactolipids present in
vegetables [11, 12] and is responsible for the degradation of
the thylakoids gradually occurring in the intestine. Thylakoids
additionally contain vitamins E and K as well as certain pig-
ments and antioxidants, like chlorophyll, carotenoids,
zeaxantin and lutein. The antioxidants protect the plant against
oxidation, induced by light, and may after consumption pro-
tect humans against disease. The bioavailablity of lutein and
zeaxantin is high [13], meaning that the antioxidants may
protect against disease, as evidenced by epidemiological stud-
ies. Chlorophyll is a green pigment that absorbs energy from
light during the photosynthetic process present in green plants
and algae. It has a structure similar to haemoglobin with a
carbon chain, called phytol. There are many health claims
about chlorophyll that has no substantial evidence. In scien-
tific literature it has nevertheless been demonstrated to act as a
protective agent against certain chemicals that induce cancer
[14]. Moreover, chlorophyll or its metabolites may activate
nuclear receptors, named PPARs [15]. These are nuclear re-
ceptors that activate genes regulating lipid metabolism, insulin
sensitivity, and glucose homeostasis. When activated they
stimulate fatty acid oxidation and decrease hyperlipidaemia
[15]. High concentrations of chlorophyll in the intestine may
therefore through activation of this nuclear receptor family
activate fatty acid oxidation in the intestinal cell. The intestinal
cell has the ability to oxidize fatty acids at a high rate [16].
Maximally 5 % of chlorophyll is absorbed in the intestine.
Most chlorophyll passes through the colon and may affect
gut health [17].
Fig. 1 A plant cell consists of chloroplasts, where the photosynthesis
takes place. The cell is surrounded by a cell wall, resistant to digestion
by humans. A vacuole with water takes up 80 % of the volume of a cell.
The thylakoids are membranes building up the photosynthetic apparatus
in the chloroplast. The thylakoids consists of galactolipids, proteins,
pigments, vitamins and antioxidants
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Effects of Thylakoids
Effect on Lipase/Colipase Activity
Our first discovery on the effect of thylakoids was a powerful
inhibition of the pancreatic lipase/colipase catalysed hydroly-
sis of fat (Fig. 2) [18]. Pancreatic lipase with its protein cofac-
tor colipase is the main enzyme responsible for hydrolysis of
dietary fat in the intestine [21]. Lack of either lipase or
colipase causes impaired fat digestion and steatorrea [22].
The idea that a reduced rate of fat digestion would affect
appetite was clear from colipase knock out mice, who in their
heterozygous form had a more slowly growth [23]. This idea
was further promoted by the discovery of a compound that
inhibited pancreatic lipase/colipase and at the same time re-
duced food intake in rat after oral administration [24].
The finding of thylakoids as inhibitors for lipase/
colipase was based on the idea that galactolipids are pow-
erful inhibitors of lipase/colipase, and that thylakoids are
a rich source of galactolipids. Pancreatic lipase and
colipase have been demonstrated to adsorb to galactolip-
ids in monolayers [25], slowing down lipolysis, which
may be important to promote satiety [26]. With our pres-
ent knowledge there are several components in the thyla-
koids that are important for the observed appetite suppres-
sion, not only the galactolipids. These components are the
proteins, i.e., light harvesting complexes and the antioxi-
dants. The whole complex macromolecular structure of
thylakoids is needed for an optimal effect on appetite sup-
pression. The thylakoids display a dose-dependent inhibi-
tion of pancreatic lipase/colipase activity in vitro. To our
surprise extraction of the lipids from the thylakoids, ren-
dering a lipid free thylakoid product still had the ability to
inhibit pancreatic lipase/colipase. Thus rather the hydro-
phobic proteins in the thylakoids are responsible for the
observed inhibition [18].
Many proteins inhibit pancreatic lipase, but in the presence
of bile salt and colipase, as occur during intestinal fat digestion
under physiological condition, there is no such inhibition [27].
The ability of thylakoids to inhibit lipase even in the presence
of bile salt and colipase is thus a completely new phenome-
non. The inhibition is not unique to thylakoid membranes. We
demonstrated this to be true also for other membranes, like
plasma membranes from animal cells, mitochondria from an-
imal cells and bacterial membranes [18]. Thylakoids are
unique, because they are extremely resistant to proteolysis
by gastric and pancreatic juice enzymes, in contrast to other
membranes [10]. This resistance of thylakoids towards intes-
tinal degradation is due to the high content of the membrane
pigments chlorophyll a and b and carotenoids which are
strongly bound to the intrinsic membrane proteins. The en-
zymes are thereby hindered to come in contact with the intrin-
sic membrane proteins. Such a stability of thylakoids is
important for the effects on appetite, energy metabolism and
intestinal bacterial flora. Mitochondria when added to food at
a concentration to inhibit pancreatic lipase/colipase were un-
able to suppress food intake and body weight in long-term
experiments in rat (unpublished experiments). Also the milk
protein casein, which is a powerful inhibitor of pancreatic
lipase/colipase failed to suppress food intake in rat. Thus,
inhibition of pancreatic lipase/colipase in vitro subsequently
does not necessarily mean a suppression of appetite and body
weight in vivo.
The synthetic compound, diethylaminoethylether inhibited
pancreatic lipase/colipase and at the same time suppressed
appetite [24]. There was however no steatorrea, explained
by an increased synthesis of pancreatic lipase leading to a
persistent fat digestion at low rate [24]. There are several in-
hibitors for pancreatic lipase, with a potential use for obesity
treatment. Orlistat (Xenical) reacts with the active site of li-
pase, in this way blocking lipase activity. The inhibition may
be partially reversed in the presence of an emulsion [28].
When used clinically this compound has been demonstrated
to cause bodyweight loss at an intermediate scale, around 5 kg
per year. The side effects are steatorrea [29]. This is not a
serious side effect as opposed to drugs that act centrally and
has driven the use of orlistat into the field of reducing blood
lipids and treating diabetes [30]. One basic difference between
thylakoids and orlistat is the release of the satiety hormones,
e.g., CCK by thylakoids [18, 31–33], but not with orlistat
[34]. The reason is that the satiety hormones are released by
fatty acids, which are the end products of triacylglycerol hy-
drolysis. Fatty acids are formed to 100 % from triacylglycerol
with thylakoids, whereas with orlistat 25 % of the dietary fat
leaves the intestine undigested. Undigested fat, i.e., triacyl-
glycerol does not release any gastrointestinal satiety peptides.
A complete fat digestion, although being at a reduced rate, is
thus a prerequisite for optimal release of satiety hormones.
A large number of various polyphenols extracted from
plants, fungi, algae, wine, green tea, and coffee have been
found to inhibit pancreatic lipase when tested in vitro [35].
Several studies indicate anti-obesity effects in animal experi-
ments, with a mechanism of action being an increased sym-
pathetic activity, increased energy expenditure and increased
oxidation of fat [36], as well as decreased nutrient absorption
[37]. More studies are needed to document appetite and body
weight suppression when administered to human.
Dietary fibres may promote satiety. Betaglucan from barley
when added to white rice promotes satiety [38] and leads to
suppressed food intake. Fibres can also bind dietary fat, which
is then excreted in faeces. Another way of eliminating fat is by
the addition of calcium ions. A high-calcium diet was found to
excrete 10 g of fat daily compared to a low-calcium diet,
leading to the excretion of 5 g of fat [39]. The mechanism is
a binding of calcium to fatty acids, which are precipitated, and
excreted through the faeces. Calcium also precipitates bile
Plant Foods Hum Nutr (2015) 70:281–290 283
salt, which are needed for the uptake of fatty acids into the
intestine.
There are various ways of increasing faecal fat excretion,
neither of these mechanism hold for thylakoids. Thylakoids
work by temporarily inhibiting pancreatic lipase/colipase dur-
ing fat digestion. The delay in fat digestion causes the lipids to
reach the distal end of the intestine, where they are absorbed.
The overall important mechanism is that the food digestion is
Bforced^ to reach the distal parts of the intestine. Thereby
satiety hormones can be efficiently released. The mechanism
for inhibition of pancreatic lipase/colipase is a binding of thy-
lakoids to the lipid surface covering the triglyceride substrate
to be hydrolysed (Fig. 2) [18]. Another mechanism is the
binding of pancreatic lipase/colipase to thylakoids. Only a
small percentage of pancreatic lipase/colipase is however
bound to the thylakoids, suggesting that the inhibition of
lipase/colipase activity is due to the covering of the triglycer-
ide surface by thylakoids. Thylakoids have emulsifying prop-
erties, which means that they are attracted to lipid surfaces,
forming stable emulsions of fat. In order to be active as appe-
tite suppressor it is important that thylakoids are dissolved in a
lipid formula, which make them optimally spread to form a
monolayer around lipid particles and on surfaces.
Promotion of Satiety and Suppression of Hunger
Administration of thylakoids inhibits eating and promotes sa-
tiety, as demonstrated in rat [18, 40], mouse [32] and human
[31, 33, 41, 42]. Chronic administration of thylakoids effec-
tively reduces body weight and improves glucose/lipid metab-
olism in overweight individuals, suggesting thylakoids to of-
fer an effective therapeutic option for overweight patients. In
animal studies thylakoids were mixed with food and in human
studies thylakoids were mixed with food ingredients as part of
a complete meal or served as a juice prior to a meal. Thyla-
koids are efficient in suppressing food intake irrespective of
the composition of diet, i.e., a high-fat [18, 31] or a high-
carbohydrate diet [33, 40–42]. The suppression of food intake
was a direct effect in human observed within the same meal
[33, 42].
In human a high-fat meal was served with increasing con-
centrations of thylakoids, from 5 to 50 g [31]. The thylakoids
were mixed with rapeseed oil (26 g) and cashew-nuts (25 g),
lime, salt and basil and was eaten as a pesto sauce on bread
with tomatoes. The percentage fat was 65 energy %, carbohy-
drate 25 E% and protein10 E%. With such a meal CCK was
released in a dose-dependent way, significantly different from
control at time point 4 h and 6 h after the start of meal. The
control meal rendered an optimal CCK release at time point
30 min after the start of meal, while with thylakoids there was
an early release of CCK at time point 30 min and a new peak
after 4 h (Fig. 3).
The time course suggests that the stimulus for release of
CCK is continued up to 6 h. Since the meal was a high-fat
meal, it could be inferred that the dietary fatty acids cause the
CCK release and that the fatty acids are formed during a
Fig. 2 Thylakoids and fat
digestion. Thylakoids inhibit
lipase/colipase activity in a dose-
dependent way [18]. The inhibi-
tion is due to the binding of thy-
lakoids to the triglyceride inter-
face, thus covering the substrate
to be hydrolysed [18, 19]. The
thylakoids also bind the pancre-
atic lipase/colipase complex [20].
The hydrolysis of the oil droplet
thus occurs more slowly. Intesti-
nal enzymes gradually break
down the thylakoids, which al-
lows fat digestion to be complet-
ed. Therefore there is no
steatorrea
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longer time period compared to control. Thus thylakoids slow
down digestion of dietary fat in man in a way that promotes
the release of CCK during a longer period of time. A further
proof of delayed fat digestion was a late appearance of fatty
acids in the blood compared to control [31]. During these
studies leptin was significantly elevated compared to control
at time point 6 h [31]. Since delipidated thylakoids inhibit
lipase as efficient as normal thylakoids [18] it was of interest
to study their potential appetite suppressive effect. The release
of CCK was similar as for normal thylakoids; however, there
was no release of leptin [31]. Delipidated thylakoids, lacking
pigments and membrane lipids, thus are not as efficient to
regulate appetite as untreated thylakoids.
Since thylakoids induce satiety in fat-rich meals, an obvi-
ous question was if thylakoids also act as appetite suppressor
in carbohydrate-rich meals. Overweight women were served a
carbohydrate-rich breakfast with and without thylakoids [33].
The meal consisted of muesli, white bread, butter, cheese,
ham, black current jam, yoghurt, orange juice, and banana
together with coffee and was followed during 4 h. The meal
consisted of 71 E% carbohydrate, 11 E% fat and 18 E%
protein by energy. The thylakoids were mixed into the jam
and eaten with yoghurt and muesli. The study had a crossover
design. The overweight women experienced a suppressed
hunger and motivation to eat after consumption of the
thylakoid-enriched breakfast compared to control breakfast
[33]. The appetite suppression became apparent after 2 h from
the start of the breakfast. A significant elevation of CCK levels
were registered from 3 h and onwards compared to control.
The study concluded that thylakoids were able to give a late
satiety and suppressed hunger motivation, even with a high-
carbohydrate meal [33]. It is important to note that the hunger
was suppressed and satiety promoted by thylakoids as early as
2 h after the start of meal, measured in a standard
carbohydrate-based breakfast [42].
The explanation for a postprandial satiety even with a high-
carbohydrate, low-fat meal suggests that other mechanisms
for the appetite suppressive effect of thylakoids unrelated to
a reduced rate of fat digestion may be relevant. One such
mechanism could be the effect of thylakoids on glucose ho-
meostasis and insulin secretion. The thylakoid-enriched
breakfast demonstrated a biphasic response of glucose levels
in the blood, whereas the control breakfast demonstrated a
single rise of glucose, followed by a hypoglycaemia postpran-
dially [33]. The hypoglycaemia in the control breakfast corre-
lated with an increased hunger. Hypoglycemia is known to
stimulate hunger, whereas a rise in blood glucose causes sati-
ety [43].
Another explanation for the increased satiety by thylakoids
may be the release of CCK and GLP-1. Release of CCK has
been postulated to occur only after fat- and protein-rich meals.
Even a carbohydrate-rich meal was found to raise CCK levels
[44]. Release of GLP-1 was significantly stimulated by thyla-
koids during consumption of a breakfast in overweight wom-
en (Fig. 4) [41]. GLP-1 is a satiety hormone, produced by
intestinal cells in response to carbohydrate and fat. In particu-
lar fatty acids are potent releasers of GLP-1. GLP-1 is a hor-
mone that is being developed as an anti-obesity drug. In our
hands thylakoids caused the endogenous release of GLP-1,
which is an easier and more physiological way to enhance
GLP-1 levels to achieve satiety and energy balance.
A suppression of the hunger signal ghrelin by thylakoids
was observed after the high-dose thylakoid in a single meal
consisting of 60 % fat and where the thylakoids were added in
a pesto sauce [31]. Ghrelin was like-wise suppressed in pig
receiving pure carbohydrate by thylakoids compared to con-
trol [45]. The effect of thylakoids on appetite regulation and
appetite regulation hormones occurs thus with both
carbohydrate- and fat- rich meals.
Suppression of Hedonic Hunger
Hedonic hunger is characterized by 1) thinking of food, al-
though you have just eaten, 2) an uncontrolled urge to eat
highly palatable food, containing sugar, salt or fat and 3) over-
eating. Overweight subjects have an increased liking of palat-
able food, in particular sugar [46] and fat [47]. It is hence of
great importance to find strategies that may promote control of
hedonic hunger.
We found that thylakoids indeed suppressed hedonic hun-
ger [41, 42, 48]. Overweight women were served a single
breakfast with or without a prior shot with thylakoids. The
liking for salt, sweet, fat and sweet/fat was estimated using a
VAS scale combined with pictures (chips, goodies, cheese on
bread and chocolate). A significant reduction in the liking of
fat and sweet was demonstrated after a single shot of
Fig. 3 The release of CCK following a meal with and without thylakoids
in human. With thylakoids there was a late release of CCK in addition to
the early release. In control there was only an early release of CCK. Thus,
thylakoids induce the release of the satiety hormone CCK during a longer
period, being important for prevention of intermeal snacking [31]
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thylakoids, the same day [41, 42, 48]. The liking decreased
further after 12 weeks of daily consumption of 5 g thylakoids
[41] (Fig. 4). It is concluded that thylakoids have the ability to
suppress urge for sweet and fat. This appears to last the whole
day following consumption of a thylakoid-enriched juice in
the morning [42]. This is particularly important since cravings
for sweet usually start in the afternoon. Thylakoids when con-
sumed in this way thus provides a powerful strategy to sup-
press the urge for palatable food. In the long-term studies
GLP-1 was significantly increased by thylakoids, both at the
first day, but even more the last day of thylakoid treatment
[41] (Fig. 4). Since GLP-1 is a strong suppressor of urge for
sweet food, the increase in GLP-1 may well explain the ob-
served decreased sweet urge. The mechanism may also in-
volve the satiety hormone CCK. Another explanation may
be the stabilization of serum glucose by thylakoids to prevent
postprandial hypoglycaemia, which otherwise triggers crav-
ing for rewarding food.
Loss of Body Weight and Body Fat
Various experiments demonstrate that thylakoids promote
weight loss in rat, mouse and in man. In rat a loss of 17,
5 % body weight (p<0,05) was noted after 13 days of
treatment with thylakoids added to a high-fat diet [18].
The loss of body weight was associated with a reduction
of serum triacylglycerol by 40 % (p<0,05).
In mice body weight loss with thylakoids was 17 % (p<0,
001) compared to control mice after 100 days of treatment
[32]. The weight loss occurred with a reduced food intake
(p<0,001) and an increased release of the satiety hormone
CCK, being increased by 52 % (p<0,05). The loss in body
weight was evident from day 28. The time delay suggests that
genes are gradually upregulated that promote satiety signal-
ling. Another explanation is a changed bacteria flora as evi-
denced after administration of thylakoids to rat [40]. Whether
an increased thermogenesis is induced by thylakoids is not
known.
The thylakoid-diet given to mice also reduced body fat
mass by approximately 33 % (p<0,001) and serum leptin by
44 % (p<0,01) [32]. The loss in body weight was thus effec-
tively a loss of fat mass, evidenced both by tissue measure-
ments using a DEXA-scanner and by leptin measurements,
leptin being representative for the amount of fat mass [49].
The loss of body fat suggests that there is an increased fatty
acid oxidation by thylakoids.
In these studies serum triacylglycerol was at the same
time reduced by 25 % (p<0,05) and serum glucose by
17 % (p<0,05), supporting the coupling between body
weight loss, fat mass loss and reduction of serum lipid/
glucose values [32]. Somewhat surprising the levels of
serum free fatty acids were also reduced after thylakoid
treatment by 16 % (p<0,05). It is remarkable that the
levels of free fatty acids were reduced by the thylakoid
diet compared to control. A loss of body weight by re-
stricted diet is often associated with an increase in the
levels of free fatty acids. Free fatty acids have a potential
to cause inflammation in pancreas, liver and the brain
[26]. The reduction of free fatty acids by thylakoids dur-
ing weight loss may thus be an important health-
promoting property.
In human, thylakoids were shown to promote body weight
loss together with reduction of blood lipids, significantly dif-
ferent from control (p<0,02) [41]. Thirty-eight women (40–
65 years of age) with a BMI of 25–33 were randomly assigned
to consume a glass of blueberry juice prior to breakfast with
thylakoids (5 g/day) or without for 12 weeks. They were rec-
ommended to eat three meals a day and exert 30 min of phys-
ical activity daily. At the end of the study, both groups had lost
body weight, but significantly more in the thylakoid-treated
group, −5,0 kg in the thylakoid group versus −3,5 kg in the
control group (p<0,01). Coupled with weight loss the most
significant changes induced by thylakoids compared to
Fig. 4 Suppressed urge for sweet and release of GLP-1 (glucagon-like
peptide 1) with and without the consumption of thylakoids. Overweight
women were served a breakfast at time point zero with or without 5 g of
thylakoids and a lunch at time point 360 min. Urge for sweet was
measured through VAS as well as GLP-1 through blood sampling. The
subjects receiving thylakoids had a significantly suppressed urge for
sweet and increased release of GLP-1 even after 90 days of body weight
loss compared to control [41]
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control was a reduction in LDL-cholesterol (p<0,05) levels.
This decrease occurred already after three weeks, thus prior to
the body weight loss. This suggests that thylakoids lower
blood lipids by other mechanisms than a weight-loss conse-
quence. The effects suggest that thylakoids may be helpful for
treatment of obesity and metabolic syndrome.
Promotion of Glucose Homeostasis
Hyperglycaemia is a major symptom in type-2-diabetes,
the most prevalent disease affecting individuals with a
westernized life-style. Prevention of hyperglycaemia is
achieved through the consumption of low-glycaemic food
in contrast to high-glycaemic food, the uses of inhibitors
of carbohydrate digestion, and the use of medical drugs
that stimulate the uptake of glucose from the blood into
peripheral cells. When using low-glycaemic food fibres
present therein bind starch, in this way slowing down
the digestion of starch into glucose. Inhibitors of starch
digestion are present naturally in the plant kingdom. One
such inhibitor is proantocyanidin in cinnamon, demon-
strated to inhibit carbohydrate hydrolysis in vitro [50].
This is an important effect to explain the blood glucose
lowering effect of cinnamon. Whether the antioxidants
present in thylakoids have any inhibiting capacity on am-
ylase activity, is not known. Regarding blood glucose it is
important also to control the absorption process. The ab-
sorption of glucose occurs through the apical brush-border
membrane of the intestinal epithelial cell, mainly through
the action of the sodium-glucose linked transporter I. In
rat intestine, glucose uptake was significantly reduced by
the presence of thylakoids in vitro [8]. The explanation
for the reduced uptake of glucose may be the localization
of thylakoids as large complex structures onto the mucosa
[8]. There may also be a binding of thylakoids to the
starch and/or amylase. In vivo, a 10-day treatment with
thylakoids in rat resulted in reduced glucose levels after
an oral glucose tolerance test [40]. This suggests an im-
proved glucose homeostasis induced by thylakoids. Thy-
lakoids also decreased blood glucose levels during long-
term treatment in rat [40], mouse [32] and pig [51]. The-
ses changes were related to the negative energy balance
following weight loss. Weight loss treatment in general
leads to improvement of glucose homeostasis, the devel-
opment of obesity often being associated with type 2 di-
abetes mellitus [1]. According to the first law of thermo-
dynamics, reduced food consumption spontaneously cre-
ates a negative energy balance, with an improvement of
the metabolic profile of the overweight person. Thus,
weight loss of 5–10 kg is sufficient to decrease plasma
levels of glucose, insulin, and blood lipids/lipoproteins
[51]. Thylakoids may thus be helpful during the treatment
of obesity and type-2-diabetes to reduce blood glucose
levels.
Reduction of Blood Triglycerides and Cholesterol
A consistent finding with long-term treatment with thyla-
koids is a reduction of blood lipids, both triacylglycerol and
cholesterol. In rat, triacylglycerol levels were reduced by
40 % following a 13-day treatment with thylakoid-
enriched food [18] and in mice reduced by 24 % following
a 100–day treatment [32]. The reduction in lipid levels oc-
curred simultaneously with a loss of body weight. A 15 %
reduction of triacylglycerol levels is a common goal for
treatment of hypertriglyceridemia [52]. Thylakoids thus
have a potential to be used as an alternative for lipid-
reducing drugs. The mechanism for the reduced levels of
blood lipids is not known. Perhaps a stimulated fatty acid
oxidation occurs through the presence of pigments in thyla-
koids [16]. Cholesterol-lowering effect may be related to
bile salt binding, thereby inhibiting the intestinal absorption
[53]. Another mechanism may be the prebiotic effect of
thylakoids [40]. Lactobacillus reuteri, a strain increased
by thylakoids in rat, has been demonstrated to decrease se-
rum cholesterol levels [54].
Prebiotic Effect of Thylakoids
Dysregulation of energy metabolism as occurs in obesity
and diabetes may be related to gut microbiota [55]. Gut
microbiota process components of the diet that have not
been digested in the small intestine. They hence take part
in nutrient acquisition and energy regulation. By produc-
ing metabolically active components they also affect glu-
cose homeostasis as well as lipid metabolism. Some bac-
teria even act as anti-obesity factors, like lactobacilli and
bifidobacteria [55, 56]. Thylakoids when administered to
rat for 10 days modulated the gut microbiota [40]. Lacto-
bacillus reuteri was significantly increased in the distal
ileum compared to control rats, whereas bifidobacteria
were not changed [40]. Lactobacillus reuteri was shown
to prevent obesity in apo-E-deficient mice given a high-fat
diet [57]. Using the same strain of mice we found that
thylakoids prevented weight gain during high-fat diet
without affecting the cholesterol levels [32], suggesting
that the anti-obesity effect of thylakoids may be linked
to a change in microbiota. Also in human thylakoids
affect the microbiota, as measured during a 10-week study
with and without thylakoids were changed (C. Montelius,
unpublished results). The change in microbiota may con-
tribute to the anti-obesity effect of thylakoids in human
and the improvement of lipid and glucose homeostasis.
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Suppression of Inflammation
Suppression of inflammation is important to prevent aging
diseases, such as atherosclerosis. Berries with their antioxi-
dants have been found extremely useful to provide a suppres-
sion of inflammation [58]. Since thylakoids contain antioxi-
dants we were interested whether these had any effect on
inflammation. TNF-alpha was suppressed after a single meal
(p<0,01) [33]. Whether such a suppression is observed after
long-time is not known, but is an important issue for long-term
health benefit.
Summary
In conclusion, thylakoids when added to food are powerful
promoters of satiety and suppressors of hunger, in particular
hedonic hunger. The mechanism is a late satiety, by the use of
the whole intestine for digestion of food. In this way satiety
hormones are released from the distal intestine, the ileal break,
providing information to the brain that satiety has been
achieved and a reduced urge for snacking. Since snacking is
an important contributor to the global epidemic of obesity
today, the consumption of thylakoids may aid in the preven-
tion of this epidemic. The effects of thylakoids are summa-
rized in Fig. 5.
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